March 10, 2026
Sandoz bets on its own new biosimilar unit with a veteran hire
A structural reorganization and a key appointment reveal a company that has moved beyond proving itself and is now building for dominance
Pharmaceuticals, Biotechnology and Life Sciences
Tag: ranibizumab
April 4, 2019
Oxurion enrolls patients to test its antibody PlGF in combinationwith Ranibizumab, to treat Diabetic Macular Edema
Belgian Oxurion has enrolled 70 patients for Phase 2 testing of its THR-317, a humanized antibody against placental growth factor (PlGF), in combination with anti-VEGF (ranibizumab), an anti-vascular endothelial growth factor (VEGF) antibody, for the treatment of Diabetic Macular Edema (DME).